Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma.

[1]  H. Ishitsuka,et al.  Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  H. Ishitsuka,et al.  Establishment and characterization of cachexia‐inducing and ‐non‐inducing clones of murine colon 26 carcinoma , 1995, International journal of cancer.

[3]  G. Strassmann,et al.  Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor. , 1993, Journal of immunology.

[4]  T. Yoneda,et al.  Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma. , 1993, Cancer research.

[5]  Robert B Sim,et al.  Human interleukin‐1 receptor antagonist is expressed in liver , 1992, FEBS letters.

[6]  G. Strassmann,et al.  Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. , 1992, Journal of immunology.

[7]  G. Strassmann,et al.  Evidence for the involvement of interleukin 6 in experimental cancer cachexia. , 1992, The Journal of clinical investigation.

[8]  K. Abe,et al.  Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. , 1991, Cancer research.

[9]  A. Billiau,et al.  Severe cachexia in mice inoculated with interferon‐γ‐producing tumor cells , 1991 .

[10]  W. Fiers.  Tumor necrosis factor Characterization at the molecular, cellular and in vivo level , 1991, FEBS letters.

[11]  F. Vidal-Vanaclocha,et al.  Quantitative microscopy of mouse colon 26 cells growing in different metastatic sites. , 1991, British Journal of Cancer.

[12]  L. Bonewald,et al.  Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice. , 1991, The Journal of clinical investigation.

[13]  C. Bucana,et al.  Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. , 1990, Journal of the National Cancer Institute.

[14]  H. Ishitsuka,et al.  Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. , 1990, Cancer research.

[15]  J. Norton,et al.  Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat. , 1988, Cancer research.

[16]  K. Tracey,et al.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation , 1988, The Journal of experimental medicine.

[17]  A. Oliff,et al.  Tumors secreting human TNF/cachectin induce cachexia in mice , 1987, Cell.

[18]  L. Moldawer,et al.  Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia. , 1987, Clinical physiology.

[19]  W. Arend,et al.  Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. , 1985, Journal of immunology.

[20]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  H. Gitelman.  An improved automated procedure for the determination of calcium in biological specimens. , 1967 .

[22]  G. Opdenakker,et al.  Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. , 1991, European journal of cancer.

[23]  L. Moldawer,et al.  Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. , 1991, Cancer research.